Delivery Order SPE2DB20D3104-SPE2DB22FV9S5

Award Date 9/26/22
Potential Completion Date 9/27/22
Potential Value $2.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of PREVNAR 13 SYRINGE 0.5ML. The contract is a Delivery Order valued at $18,055.24 with a completion date of June 13, 2022. It is a Firm Fixed Price contract, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of PREVNAR 13 SYRINGE 0.5ML. The $27,280.20 firm fixed-price delivery order has a completion date of July 26, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award, valued at $134,830.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the procurement of PREVNAR 13 SYRINGE 0.5ML, a critical medical commodity, for a period ending on March 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award is for the delivery of PREVNAR 13 syringes (0.5 ml) to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, as a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $56,597.40 firm fixed-price delivery order is for the supply of PREVNAR 13 syringes (0.5mL) and has a completion date of July 17, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through November 2026....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is for the delivery of PREVNAR 13 SYRINGE 0.5ML, a pharmaceutical product, under a Delivery Order contract with a Firm Fixed Price pricing type. The contract has a ceiling value of $7,780.25 and a period of performance through February 29, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,394.54 firm-fixed-price delivery order is for the supply of PREVNAR 13 SYRINGE 0.5ML, a vaccine product. The contract has a completion date of June 27, 2023 and was awarded on June 26, 2023. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $30,950.25 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PREVNAR 13 SYRINGE 0.5ML, a vaccine product, with an ultimate completion date of January 16, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,712.94 firm fixed-price delivery order is for the supply of PREVNAR 13 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of June 22, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $83,215.60 firm fixed-price delivery order is for the supply of PREVNAR 13 SYRINGE 0.5ML, a pneumococcal vaccine product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB22FV9S5
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of PREVNAR 13 SYRINGE 0.5ML. The $2,310.11 firm fixed-price delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract, which does not have a set-aside designation, is set to be completed by September 27, 2022. This award demonstrates AmerisourceBergen's role as a critical supplier of essential medical commodities to the Department of Defense and other government agencies.

Generated 2/27/25, 1:32 PM